Malajsie - angličtina - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

zuellig pharma sdn bhd - tegafur; gimeracil; oteracil potassium -

Malajsie - angličtina - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

zuellig pharma sdn bhd - tegafur; gimeracil; oteracil potassium -

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

gilead sciences ltd - amphotericin b liposomal - powder for dispersion for infusion - 50mg

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

gilead sciences pty ltd - amphotericin b -

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

gilead sciences (nz) - amphotericin b 50mg - powder for injection - 50 mg - active: amphotericin b 50mg excipient: cholesterol hydrochloric acid alpha-tocopherol distearoylphosphatidylglycerol phosphatidylcholines, soya, hydrogenated phosphatidylglycerols as sodium salt sodium hydroxide sodium succinate sucrose - ambisome is indicated for: · prophylaxis in liver transplant patients at risk of systemic candida, aspergillus and cryptococcus infections, and for · the treatment of systemic fungal infections caused by organisms susceptible to amphotericin b. ambisome is indicated for empirical treatment of presumed fungal infections in febrile neutropaenic patients whose fever has failed to respond to broad spectrum antibiotic treatment. ambisome is indicated for the treatment of visceral leishmaniasis. clinical studies of efficacy in visceral leishmaniasis are limited to leishmania infantum.

Kanada - angličtina - Health Canada

leadiant biosciences, inc - amphotericin b - suspension - 5mg - amphotericin b 5mg - polyenes

Kanada - angličtina - Health Canada

astellas pharma canada inc - amphotericin b - powder for solution - 50mg - amphotericin b 50mg - polyenes

Kanada - angličtina - Health Canada

three rivers pharmaceuticals llc - amphotericin b - powder for suspension - 100mg - amphotericin b 100mg - polyenes

Kanada - angličtina - Health Canada

three rivers pharmaceuticals llc - amphotericin b - powder for suspension - 50mg - amphotericin b 50mg - polyenes

Spojené státy - angličtina - NLM (National Library of Medicine)

leadiant biosciences, inc. - amphotericin b (unii: 7xu7a7droe) (amphotericin b - unii:7xu7a7droe), dimyristoylphosphatidylcholine, dl- (unii: u86zgc74v5) (dimyristoylphosphatidylcholine, dl- - unii:u86zgc74v5), dimyristoylphosphatidylglycerol, dl- (unii: bi71wt9p3r) (dimyristoylphosphatidylglycerol, dl- - unii:bi71wt9p3r) - amphotericin b 5 mg in 1 ml - abelcet ® is indicated for the treatment of invasive fungal infections in patients who are refractory to or intolerant of conventional amphotericin b therapy. this is based on open-label treatment of patients judged by their physicians to be intolerant to or failing conventional amphotericin b therapy (see description of clinical studies). description of clinical studies fungal infections data from 473 patients were pooled from three open-label studies in which abelcet ® was provided for the treatment of patients with invasive fungal infections who were judged by their physicians to be refractory to or intolerant of conventional amphotericin b, or who had preexisting nephrotoxicity. results of these studies demonstrated effectiveness of abelcet ® in the treatment of invasive fungal infections as a second line therapy. patients were defined by their individual physician as being refractory to or failing conventional amphotericin b therapy based on overall clinical judgement after receiving a minimu